对专用和非标签的跨导管器件进行元分析,用于原生大动脉吐
Sahar Samimi1, Taha Hatab1, Chloe Kharsa1
1Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
JACC. Cardiovascular interventions
|November 21, 2024
概括
针对本源性大动脉吐 (AR) 的专用跨导管大动脉置换 (TAVR) 设备显示出比标签外设备更好的结果. 这些专用TAVR设备可以降低高风险患者的死亡率和再干预率.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 严重的先天性大动脉反 (AR) 对高风险的手术患者构成挑战.
- 像JenaValve和J-Valve这样的专用跨导管大动脉置换 (TAVR) 设备显示出有前途.
研究的目的:
- 为了比较专用TAVR设备与非标签TAVR设备的安全性和有效性.
- 专注于具有纯原生AR的高风险患者.
主要方法:
- 在PubMed,EMBASE和Cochrane Central的系统文献搜索.
- 34项涉及2,162名患者的研究的元分析.
- 主要终点:30天全因死亡率;次要终点包括设备成功,残留AR和1年后死亡率.
主要成果:
- 专用TAVR设备的30天死亡率较低 (3%对9%) 和设备成功率更高 (93%对82%).
- 通过专门的设备观察到中度或重度AR,膜栓塞,心脏起器植入和重新干预的减少率.
- 一年内全因死亡率与专用设备相比显著降低 (6%vs24%).
结论:
- 针对本地AR的专用TAVR设备提供了卓越的设备成功率和降低的死亡率,残留AR和重新干预率.
- 研究结果支持专用设备作为高风险患者接受TAVR治疗本地AR的更安全的替代方案.
相关概念视频
Aortic Regurgitation I: Introduction
3
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
3
Aortic Regurgitation IV: Nursing Management
12
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12
Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4


